Cardioprotective reperfusion strategies differentially affect mitochondria:studies in an isolated rat heart model of donation after circulatory death (DCD). by Sanz-Garcia, Maria Nieves et al.
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
11
88
46
 
| 
do
wn
lo
ad
ed
: 
6.
1.
20
20
A
cc
ep
te
d 
A
rt
ic
le
This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1111/ajt.15024 
This article is protected by copyright. All rights reserved. 
DR MARIA NIEVES SANZ (Orcid ID : 0000-0002-5479-1114) 
 
Article type      : Original Article 
 
Cardioprotective reperfusion strategies differentially affect mitochondria: 
studies in an isolated rat heart model of donation after circulatory death (DCD) 
 
Maria N. Sanz1, Emilie Farine1,$, Petra Niederberger1,$, Natalia Méndez-Carmona1, Rahel K. 
Wyss1, Maria Arnold1, Patrik Gulac1,2, Georg M. Fiedler3, Mélanie Gressette4, Anne Garnier4, 
Thierry P. Carrel1, Hendrik T. Tevaearai Stahel1*, Sarah L. Longnus1  
 
1Department of Cardiovascular Surgery, Inselspital, Bern University Hospital and 
Department for BioMedical Research, University of Bern, Bern, Switzerland 
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, 
Bratislava, Slovak Republic 
3Center of Laboratory Medicine, University Institute of Clinical Chemistry, University 
Hospital, Inselspital, Bern, Switzerland 
4UMR-S 1180, INSERM, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, 
France 
 
$Equally contributed 
*To whom correspondence should be addressed: 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Prof. Dr. Hendrik T. Tevaearai Stahel 
Department for Cardiovascular Surgery 
Inselspital, Bern University Hospital and University of Bern 
CH-3008 Bern 
T +41 76 380 4835 
email: hendrik.tevaearai@gmail.com 
 
List of abbreviations: 
AK, adenylate kinase; ATP, adenosine triphosphate; AU: arbitrary units; CF, coronary flow; 
CI, mitochondrial complex I; CII, mitochondrial complex II; CK, creatine kinase; CO, cardiac 
output; COX, cytochrome c oxidase (mitochondrial complex IV); CS, citrate synthase; cyt c, 
cytochrome c; DBD, donation after brain death; DCD, donation after circulatory death; DP, 
developed pressure; dP/dtmax, maximum first derivative of left ventricular pressure; dP/dtmin, 
minimum first derivative of left ventricular pressure; HR, heart rate; HY, hypoxia; IR, 
ischemia and reperfusion; IU, international unit; KHB, Krebs-Henseleit bicarbonate buffer; 
LDH, lactate dehydrogenase; LV, left ventricular; MH, mild hypothermia; MPC, mechanical 
post-conditioning; min, minute(s); mtDNA, mitochondrial DNA; mtDNA:nDNA, mitochondrial 
DNA-nuclear DNA ratio; mtPTP, mitochondrial permeability transition pore; nDNA, nuclear 
DNA; N.D, non detectable; O2, oxygen; O2C, oxygen consumption; O2:T, oxygen 
consumption-triple product ratio; PCr, phosphocreatine; ROS, reactive oxygen species; sec, 
second(s); SD, standard deviation; TBARS, thiobarbituric acid reactive substances; TnT, 
troponin-T; vs., versus; wt, weight 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Abstract 
Donation after circulatory death (DCD) holds great promise for improving cardiac graft 
availability, however concerns persist regarding injury following warm ischemia, after donor 
circulatory arrest, and subsequent reperfusion. Application of pre-ischemic treatments is 
limited for ethical reasons, thus cardioprotective strategies applied at graft procurement 
(reperfusion) are of particular importance in optimizing graft quality. Given the key role of 
mitochondria in cardiac ischemia-reperfusion injury, we hypothesize that three reperfusion 
strategies: mild hypothermia, mechanical post-conditioning and hypoxia, when briefly applied 
at reperfusion onset, provoke mitochondrial changes that may underlie their cardioprotective 
effects. Using an isolated, working rat heart model of DCD, we demonstrate that all three 
strategies improve oxygen-consumption–cardiac-work coupling and increase tissue ATP 
content, in parallel with increased functional recovery. These reperfusion strategies, 
however, differentially affect mitochondria; mild hypothermia also increases phosphocreatine 
content, while mechanical post-conditioning stimulates mitochondrial complex I activity and 
reduces cytochrome c release (marker of mitochondrial damage), whereas hypoxia up-
regulates the expression of Pgc-1α (regulator of mitochondrial biogenesis). Characterisation 
of the role of mitochondria in cardioprotective reperfusion strategies should aid in the 
identification of new, mitochochondrial-based therapeutic targets and the development of 
effective reperfusion strategies that could ultimately facilitate DCD heart transplantation. 
 
1. Introduction 
Heart transplantation is currently the best option to improve quality of life and life 
expectancy of patients suffering from end-stage heart failure. However, the number of 
donors is largely insufficient to cover the ever-increasing demand for hearts in both the EU 
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and the US (1,2). One promising solution to this recurrent shortage is the use of grafts 
obtained from donors after circulatory death (DCD) (3).  
Despite ground-breaking demonstrations of clinical DCD heart transplantation in the last 
four years (4–7), concerns about graft quality persist. Indeed, DCD hearts are inevitably 
exposed to warm, global ischemia between circulatory arrest and procurement that can 
rapidly lead to tissue damage. Nonetheless, donor hearts can withstand a short period of 
warm ischemia; its duration has been limited to 30 min in recent DCD heart transplantations 
(8).  
As interventions in DCD donors are limited for ethical reasons, cardioprotective therapies 
applied immediately following the period of warm ischemia hold great promise to increase 
graft tolerance to ischemia-reperfusion-induced injury (9–12). In current clinical practice, 
cardiac grafts are reperfused immediately following warm ischemia with either cold 
cardioplegia supplemented with erythropoietin and glyceryl nitrate with (4) or without (5) 
heparin (direct procurement protocol), or they are reperfused in situ, following heparinization, 
with donor blood (normothermic regional perfusion protocol) (6). Therefore, differing 
approaches are used for reperfusion following warm ischemia in the clinical setting, and it is 
likely that further development of alternative and/or complementary reperfusion strategies 
will contribute towards the optimization of graft quality (8).  
Mitochondria play an important role in cardiac ischemia-reperfusion (IR) injury. During 
cardiac ischemia, reliance on glycolysis leads to intracellular acidosis and Ca2+ overload, 
which contribute to the progressive deterioration of mitochondrial structure and function (13). 
During reperfusion, recovery of mitochondrial oxidative phosphorylation for ATP generation 
is a critical requirement for recovery of cardiac function. However, mitochondria themselves 
contribute to cellular damage at reperfusion, through the exacerbated production of reactive 
oxygen species (ROS). ROS damage cellular membranes and increase the sensitivity of 
mitochondrial permeability transition pore (mtPTP) to Ca2+ (13). With the normalization of 
intracellular pH at the onset of reperfusion, these processes lead to the opening of mtPTP, 
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which can trigger mitochondrial destruction and cell death (13). For these reasons, 
preservation of mitochondrial function and integrity during the first minutes of reperfusion is 
of central importance for optimizing recovery of hearts exposed to warm ischemia (14,15).  
We have previously described three physical strategies as cardioprotective: mild 
hypothermia (MH), mechanical postconditioning (MPC), and hypoxia (HY); when applied 
during the first minutes of reperfusion following global, warm ischemia (9). Interestingly, MH 
has been reported to prevent mtPTP opening when applied at reperfusion for 1 hour or 30 
min in both, in vivo or in vitro models of IR, respectively (16,17). In addition, MPC has been 
linked with better preserved mitochondrial function, including limited ROS production and 
delayed mtPTP opening (10,18–21). Furthermore, although HY would be expected to protect 
mitochondria by reducing or slowing the ROS burst at reperfusion, its antioxidative effect is 
still under debate (22,23). In summary, MH, MPC and HY all demonstrate cardioprotective 
effects and although underlying mechanisms remain incompletely understood, evidence 
supports roles for cardiac mitochondria. 
Therefore, we hypothesize that all three physical cardioprotective strategies: MH, MPC 
and HY, provoke mitochondrial changes which may underlie their cardioprotection effects. In 
this study, we report our investigation into mitochondrial changes induced by the application 
of these strategies in an isolated rat heart model of DCD.  
 
2. Materials and methods 
2.1. Animals and ethical statement. Male Wistar rats obtained from Janvier Labs (Le 
Genest-Saint-Isle, France) were housed under standard conditions with unrestricted access 
to food and water. Animal handling was in compliance with the European legislation 
(86/609/EEC) and the Swiss Animal Protection Ordinance. 
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2.2. Study design. An isolated, perfused heart was used as a model of DCD. Importantly, 
this model was used to simulate the period of warm, global ischemia, to which DCD organs 
are exposed. In our experimental model, hearts were perfused ex situ prior to ischemia, and 
cardioprotective strategies were applied using a warm (30 or 37°C), physiologic crystalloid 
buffer perfusate in order to precisely control the conditions to which the hearts are exposed 
and to limit potentially negative effects in donor blood or cold cardioplegia. Furthermore, 
directly after the application of cardioprotective strategies in an initial period of unloaded 
reperfusion, we proceeded with a loaded perfusion period to assess functional recovery in 
order to limit the effects of potentially confounding factors that may occur with additional 
cardioplegic/storage periods. 
Prior to anesthesia, hearts were randomly allocated to one of five parallel-arm, experimental 
groups: 1) control (non-treated ischemic group); 2-4) MH, MPC or HY (treated ischemic 
groups); and 5) sham (non-ischemic control group; Figure 1).  
2.3. Isolated, working heart preparation. Hearts were procured and initially perfused in  
Langendorff-mode with modified Krebs-Henseleit bicarbonate buffer (KHB) within 2 min of 
diaphragm transection (9). The left atrium was then cannulated, and the perfusion switched 
to loaded (working) mode (24). 
2.4. Perfusion protocol. All hearts were initially submitted to 20 min of aerobic, working 
baseline perfusion (afterload 80 mmHg) with modified KHB (9). During this period, the 
perfusate was supplemented with 1.2 mM palmitate and 3% bovine serum albumin to 
simulate high pre-ischemic circulating fatty acid levels, as expected in clinical DCD (25). 
Unless otherwise stated, perfusion buffers were oxygenated with 95% O2/5% CO2  to 
achieve a pO2 of 550 mmHg, and maintained at 37°C. 
Control, MH, MPC and HY groups then all underwent 27 min warm (37°C), global ischemia; 
perfusate lines were clamped and hearts were immersed in energy-substrate-free KHB 
bubbled with 95% N2/5% CO2. Hearts in the sham group were maintained under baseline 
perfusion conditions for the equivalent ischemic duration. 
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All groups underwent reperfusion for 60 min with modified KHB (no palmitate 
supplementation). Reperfusion was initiated in unloaded mode for the first 10 min and then 
switched to loaded mode for the remaining 50 min (afterload 60 mmHg). Afterload pressure 
was set to 60 mmHg during reperfusion to ensure sufficient perfusion and limit the risk of 
exacerbated post-ischemic damage (26). Reperfusion strategies were applied as previously 
described (9): MH, perfusate at 30°C for the first 10 min of reperfusion; MPC, 2 cycles of 30 
sec reperfusion and 30 sec ischemia; and HY, perfusate bubbled with 95% N2/5% CO2 for 
the first 2 min reperfusion.  
 
Detailed methods for the measurements of contractile cardiac function, biochemical and 
molecular parameters can be found in Supplemental materials. 
 
3. Results 
3.1. Baseline characteristics. Absolute values for perfusion parameters measured at 20 
min of baseline, as well as rat body and heart weights, are presented in Table S1. A total of 
39 rats were included: sham (n=8); control (n=8); MH (n=8); MPC (n=8); HY (n=7). All 
parameters were similar between the ischemic non-treated (control) group and reperfusion-
strategy groups, except for a higher body weight in the HY group (p <0.05). Baseline values 
measured for the sham group tended, however, to differ from other groups and some, 
essentially CO, reached statistical significance.  
3.2. Post-ischemic recovery. Cardiac recovery is presented as percentage (60 min 
reperfusion value expressed as a percentage of mean pre-ischemic value; Figure 2A-H). 
Percentage recovery was significantly reduced in control compared to sham hearts for all 
parameters. All reperfusion strategies significantly improved LV work compared to control 
hearts (p <0.05 HY; p <0.001 MH and MPC; Figure 2A). Most other parameters were 
significantly improved with reperfusion strategies compared with control hearts, although the 
profile of significant differences varied among strategies (Figure 2B-H). No difference among 
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groups was observed for recovery of CF (data not shown). Absolute values for these 
parameters at 60 min reperfusion are shown in Table S2. 
3.3. Oxygen metabolism. Oxygen consumption (O2C) was significantly decreased at 20, 
40, and 60 min reperfusion in control versus sham hearts (p <0.05 for all), and significantly 
increased with MPC compared to controls at 40 and 60 min reperfusion (p <0.05 at 40 min; p 
<0.01 at 60 min; Figure 3A). Oxygen consumption-triple product ratio (O2:T), a marker of the 
coupling between cardiac oxygen consumption and the work performed, with a higher value 
indicating a greater uncoupling, is shown in Figure 3B. O2:T was significantly increased in 
control vs. sham at 20 and 40 min reperfusion (p <0.05 for both) and then decreased to 
sham values at 60 min reperfusion. All three strategies prevented the ischemia-induced 
increase and the corresponding values were significantly lower than control values at 40 min 
reperfusion (p <0.05 all vs. control). Absolute values for these parameters at 60 min 
reperfusion are shown in Table S2.  
3.4. Release of markers of cellular death and mitochondrial damage during 
reperfusion. Release of troponin-T (TnT) and cytochrome c (cyt c), as well as lactate 
accumulation, were significantly increased in control versus sham hearts at all time points (p 
<0.05 for all; Figure 4A, C, D). LDH was not detectable (N.D) in sham hearts (Figure 4B). 
MPC was the only strategy to significantly modify these markers compared to control hearts; 
specifically, MPC increased TnT release at 10 min reperfusion (p <0.05, Figure 4A) and 
decreased the release of cyt c at 40 min reperfusion (p <0.05, Figure 4C). 
3.5. Myocardial energy status. ATP content measured at 60 min reperfusion was reduced 
by 62% in the control compared to the sham group (p <0.001; Figure 5A). Interestingly, all 
reperfusion strategies partially restored ATP levels (p <0.05 MPC and HY vs. control; p 
<0.001 MH vs. control). PCr content was also reduced in the control compared to sham 
group (p <0.05), but to a lesser extent than ATP (25% reduction; Figure 5B), and MH 
restored PCr content (p <0.05 MH vs. control) to values comparable to those in sham hearts. 
In parallel with ATP, ADP content was reduced by 44% in the control compared to the sham 
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group (p <0.05; Figure 6C). ADP content was also reduced in all reperfusion strategy groups 
vs. sham (p <0.01 for all), and appeared to be slightly lower than that in the control group, 
although not statistically different. Consequently, the ATP/ADP ratio was almost identical in 
ischemic non-treated (control) and sham hearts, and it tended to be slightly increased, 
although not statistically significant, in all reperfusion strategy groups (Figure 5 D).  
3.6. Mitochondrial-related enzymes activity. Of all mitochondrial-related enzyme activities, 
only mitochondrial complex I (CI) was significantly decreased (25%) in control vs. sham 
groups (p <0.05; Figure 6A). MPC was the sole strategy that increased mitochondrial CI 
activity compared with controls (p <0.05). No significant difference among groups was 
observed for mitochondrial complex II (CII) (Figure 6B) or adenylate kinase (AK) (Figure 6C). 
Although creatine kinase (CK) activity was not modified in control vs. sham groups (Figure 
6D), it was significantly increased in HY compared to sham, MH and MPC hearts (p <0.01 
sham vs. HY; p <0.05 MH and MPC vs. HY). 
3.7. Mitochondrial content. No significant difference was observed between control and 
sham groups for citrate synthase (CS) activity (Figure 7A), nor for cytochrome c oxidase 
(COX) activity (Figure 7B). In contrast, the mtDNA:nDNA (mitochondrial DNA-nuclear DNA 
ratio) was significantly increased in control compared to sham hearts (p <0.001; Figure 7C). 
Reperfusion strategies did not modify any of these parameters compared to control values. 
3.8. mRNA expression of genes involved in mitochondrial biogenesis. 27 min ischemia 
followed by 60 min reperfusion did not significantly modify the mRNA expression of genes 
involved in the mitochondrial biogenesis pathway (Figure 8 A-E). HY was the sole strategy to 
significantly elevate the expression of PCG-1α, a master regulator of mitochondrial 
biogenesis, compared to the control group (p <0.05; Figure 8D). 
3.9. Markers of oxidative stress. Cardiac TBARS content was similar among experimental 
groups (Figure 9A), while protein carbonylation was significantly increased in control vs. 
sham hearts (p <0.01; Figure 9B). Reperfusion strategies did not modify either of these 
parameters compared to control values. 
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3.10. Correlations between mitochondrial, metabolic, and contractile parameters. 
Correlation analyses were performed to investigate relationships between cardiac recovery 
at 60 min reperfusion and either, i) mitochondrial-related parameters at 60 min reperfusion 
(Figure 10), or ii) mitochondrial- and cell death- related parameters at early (10 min) 
reperfusion (Figure 11). Significant correlations in both analyses revealed differing profiles 
among strategies. 
 
4. Discussion 
Using our isolated, working rat heart model of DCD, we report that three, briefly applied 
reperfusion strategies, MH, MPC, and HY, improve the post-ischemic cardiac functional 
recovery in association with modification of mitochondrial-related parameters. Although 
these strategies induced differing effects on mitochondria, all provoked a greater recovery of 
ATP stores and quicker normalization of oxygen consumption-cardiac work coupling 
compared to untreated controls. To our knowledge, this is the first demonstration that a 
reduction in temperature of a few degrees, applied as a cardioprotective strategy alone for 
only the first few minutes of reperfusion (MH), leads to increased tissue content of ATP and 
PCr one hour later. We also report for the first time that with MPC, mitochondrial CI activity is 
increased in parallel with tissue ATP content and reduced mitochondrial damage. Likewise, 
our study provides the first demonstration that short application of HY at reperfusion onset 
preserves cardiac contractile function and improves ATP content subsequently. A more 
comprehensive understanding of the mechanisms of action underlying cardioprotection 
provided by the reperfusion strategies should help in the development of new therapeutic 
tools, which may ultimately be used to promote optimal recovery of graft function in DCD 
hearts.  
In pre-clinical models of DCD, cardioprotective effects of MH have been previously 
reported when applied for longer periods during reperfusion (1-3 hours) (27,28), or when 
applied in combination with other cardioprotective conditions/agents during the first minutes 
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of reperfusion (29). However, our study is the first to investigate MH as a sole strategy when 
applied for a brief period at the onset of reperfusion. We demonstrate that MH induces 
preservation of cardiac contractile function in association with greater replenishment of high 
energy metabolites (ATP and PCr). This finding is in agreement with that of Tolboom, also in 
a rat model of DCD, in which MH applied for 1 hour reperfusion led to increased repletion of 
ATP levels compared to non-treated ischemic hearts (27). Therefore, although various MH 
treatments have been demonstrated to increase mitochondrial respiration (16), delay mtPTP 
opening (16) or reduce cellular oxidative stress (27), our results reveal that only a very short 
application of MH (10 mins) at the beginning of reperfusion is required to induce a significant 
improvement in repletion of high-energy metabolites over the first hour of reperfusion.  
We also report that MPC preserves post-ischemic cardiac function, in association with 
increased ATP levels and mitochondrial CI activity. MPC is a reperfusion strategy that has 
been widely studied (10,18–21,30–32), although its precise mechanism of action remains to 
be elucidated. Our observation of MPC-induced increases in cardiac ATP content agrees 
with previous studies (19,20,30), and it is tempting to speculate that increased mitochondrial 
CI activity contributes to these higher ATP levels. However, previous studies have 
demonstrated varying effects of MPC on mitochondrial CI activity (10,18,31). It should be 
noted that mitochondrial CI is of particular importance in IR injury as it is the main cellular 
producer of ROS (33). As such, our finding of higher mitochondrial CI activity could be 
associated with higher ATP synthesis, but as well, it could also lead to excessive ROS 
production. Importantly, in MPC hearts compared with controls, cyt c release, a recognized 
indicator of mitochondrial damage (34) was significantly reduced at 40 min reperfusion and 
oxidative stress at 60 min reperfusion was not increased (although we cannot exclude that 
greater oxidative stress was induced by MPC at earlier reperfusion timepoints). Thus, our 
findings support the concept that MPC-induced mitochondrial CI activation and preserved 
mitochondrial integrity, which may contribute to greater ATP content and contractile 
recovery. 
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To our knowledge, we are the first to reveal that short hypoxic conditions at reperfusion 
onset (HY), promote post-ischemic recovery of cardiac contractile function in parallel with 
higher ATP content. HY was aimed to reduce the burst of mitochondrial ROS production that 
accompanies oxygen re-introduction at reperfusion. However, others have reported that 
similar strategies provoke either cardioprotection and antioxidant effects (22,35), or a lack of 
protection in combination with heightened oxidative stress (23). We did not observe HY-
induced reductions in overall (net) oxidative stress; however, our investigations do not 
provide insight as to whether ROS production and/or antioxidant capacity in these hearts 
was altered by HY – further investigation is required to answer these specific questions. 
Strikingly, we demonstrate for the first time that HY increases CK activity compared to most 
other experimental conditions. This is of particular interest in light of recent reports that in 
vitro (36) or ex vivo (37) overexpression of specific CK isoforms is cardioprotective. Thus, 
our novel demonstration of HY-induced CK activation merits futher investigation to determine 
its importance in cardioprotection, as well as the underlying mechanisms.  
The application of reperfusion strategies stimulated ATP repletion during reperfusion. We 
report a substantial decrease in tissue ATP content after 27 min warm, global ischemia and 
60 min reperfusion; a 62% reduction vs. non-ischemic values. This marked decrease 
contrasts with studies using unloaded (Langendorff) heart perfusions (19,20,27,30). In our 
study, the maximum reperfusion-strategy-induced repletion reached approximately 50% non-
ischemic values, whereas in “unloaded” models, similar strategies fully restored the ATP 
content (19,20,27,30). It is unclear why we observe lower post-ischemic ATP levels, but it 
may be due to greater ATP demand as a consequence of our experimental conditions: tight 
ischemic temperature control (36.5°C-37.2°C) and a loaded heart preparation (38). We also 
report a drop in tissue ADP content after IR, similar to other animal models (39,40). 
However, reperfusion strategies tended to further decrease ADP levels, leading to a trend 
towards higher ATP/ADP ratios in reperfusion-strategy, compared to control groups, 
although these changes did not reach statistical significance. Interestingly, it has been 
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suggested that during reperfusion, cardiac ATP is partially restored at the expense of ADP 
and AMP (39,40), which is consistent with the tendency that we observe, for  an increased 
ATP/ADP ratio following application of reperfusion strategies. Nonetheless, there appears to 
be considerable room for improvement in efficacy of the strategies with respect to ATP 
repletion. Possible approaches could include perfusate supplementation with stimulators of 
ATP synthesis, such as adenosine (41), trimetazidine (42) or bendavia (43,44). 
We did not observe IR-induced changes in the activities of CII, AK, and CK. These 
findings are comparable to previous reports in heart homogenates (45) or isolated 
mitochondria (46). Interestingly, Lee (46) demonstrated that IR modulates the activities of 
mitochondrial electron transport chain complexes (I-IV) differently. While activities of all 
complexes (I-IV) were reduced after ischemia, activities of complexes II and IV returned to 
pre-ischemic levels after 1 hour reperfusion (46). Thus, it could be that at the time of our 
analysis, after 1 hour reperfusion, ischemia-induced alterations in mitochondrial-related 
enzymes had already been normalized. Studies aimed to unravel the mechanisms of action 
at early reperfusion are therefore envisaged. 
We monitored three different indicators of mitochondrial mass. While the post-ischemic 
activities of CS and COX were unchanged between sham and control groups, the 
mtDNA:nDNA was substantially elevated in control compared to sham hearts. Unchanged 
mitochondrial enzyme activities are comparable to previous reports (45,46). However, 
varying effects of cardiac IR on mtDNA have been reported. IR has been associated with 
mtDNA damage at early reperfusion (47) and upregulation of genes involved in mtDNA 
replication (45). The IR-induced increase in mtDNA:nDNA that we observe should be 
interpreted with caution due to the short timeframe of our study (1 hour reperfusion). Unlike 
the study of Marin-Garcia (45), we did not observe modifications in the activation of the 
mtDNA transcription. However, the higher release in cyt c that we report after IR does 
suggest greater mitochondrial damage. Therefore, the increased mtDNA:nDNA in control vs. 
sham hearts might be a consequence of accumulated  mitochondrial damage within the cell, 
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due to inefficient mitophagy. Indeed, lack of mitophagy has previously been associated with 
exacerbated IR injury (48,49). Interestingly, in our study, HY significantly increased mRNA 
levels of Pgc-1α, the master regulator of mitochondrial biogenesis. HY-induced Pgc-1α 
expression, which has been described in cardiomyocytes after 24 hours exposure to hypoxia 
(50), is intriguing as a potential contributor to cardioprotection, and may thus prompt  further 
studies. 
TBARS and protein carbonylation were investigated as markers of oxidative stress. No 
difference among experimental groups was observed for TBARS. Indeed, it has been shown 
that TBARS may provide a better marker of oxidative stress at early reperfusion (51). 
However, protein carbonylation was significantly increased in control vs. sham hearts, and 
reperfusion strategies did not limit this increase. Contrary to previous reports (17,22,52), our 
reperfusion strategies were ineffective against post-ischemic oxidative stress. Thus, the 
administration of anti-oxidative stress therapies, such as MitoQ (53), in conjunction with our 
reperfusion strategies may further improve cardioprotective effects through complementary 
mechanisms. 
Correlation analyses between parameters of functional recovery and mitochondrial- and 
metabolic-related parameters support the notion of differing mechanisms of action for MH, 
MPC and HY and highlight new, interesting findings. For correlations between 60 min 
reperfusion parameters, O2C positively correlated with CO and ATP content for all three 
strategies, as would be expected with functional mitochondria. Although correlation findings 
suggest that mitochondrial function is preserved in conjunction with cardiac output for all 
strategies, diverging correlation patterns for other parameters were revealed. For example, 
with MH, ATP and PCr correlate positively with recovery of function (LV work and CO), while 
with MPC, mitochondrial CI and II activities correlate positively with functional parameters 
(HR, dP/dtmax, LV work and CO) and with HY, mitochondrial CII activity correlates negatively 
with dP/dtmax. Further studies are required to investigate the involvement of mitochondrial 
CII, and its utility as a potential therapeutic target in the setting of both MPC and HY 
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strategies. For correlation analyses between parameters measured at early reperfusion (10 
min) and recovery parameters (at 60 min reperfusion), early mitochondrial damage 
(determined by cyt c release) does not appear to be associated with recovery parameters in 
any experimental group. Interestingly, with MPC, early reperfusion O2:T correlates with 
measures of contractile recovery; therefore early reperfusion O2:T may be predictive of 
recovery of graft function. Also in MPC-treated hearts, early reperfusion TnT release (marker 
of cell death) positively correlates with several functional parameters, and was significantly 
increased at 10 min reperfusion compared with controls. Thus, it seems that the MPC-
induced myocardial damage at early reperfusion described by Farine (8) may be necessary 
for subsequent cardioprotection.  
We would like to highlight several limitations that apply to our work. Firstly, in order to limit 
variability and to precisely control our experimental conditions, we used an isolated heart 
model, which is not fully representative of conditions to which human cardiac grafts are 
exposed in clinical DCD. Indeed, hearts in our model are not subjected to the catecholamine 
surge and pulmonary vasoconstriction, previously described in larger animal models of DCD 
after withdrawal of life-sustaining therapy (54,55) that are particularly damaging for the right 
ventricle. Furthermore, we must also point-out that our post-ischemic findings can be 
considered only as short-term recovery as we monitored heart function for a total of one hour 
after reperfusion onset. This is of particular clinical relevance as graft dysfunction may not 
develop until several hours post-transplant. In addition, we have included only males in our 
study in order to avoid gender-related variability in the response to IR injury due to hormonal 
differences (56). Nonetheless, gender differences are potentially of great relevance in 
cardioprotection and merit further investigation. Importantly, we consider these findings as a 
first step towards better understanding of IR injury and its underlying mechanisms. Additional 
study and confirmation of these findings will be required prior to clinical translation. 
In summary, we provide evidence to support the concept that three cardioprotective 
reperfusion strategies (MH, MPC and HY) act, at least in part, by modifying mitochondrial 
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function, energy production and/or transfer through differing mechanisms. Although these 
strategies are effective, room for improvement remains. Indeed, a better understanding of 
the exact mechanisms of action for each strategy would help to identify new and 
complementary therapeutic targets, which could lead to the development of more robust 
reperfusion strategies and, ultimately, aid in the optimization of post-transplant function of 
DCD hearts.  
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Figure legends 
Figure 1. Experimental design. Hearts were randomly allocated to one of 5 parallel-arm, 
experimental groups: 1) control group, hearts were subjected to warm, global ischemia and 
reperfusion with no cardioprotective strategy; 2-4) treated ischemic groups, immediately 
following warm, global ischemia one controlled reperfusion strategy (MH, MPC or HY) was 
applied; and 5) sham group (non-ischemic control), hearts were perfused in aerobic 
conditions for the entire perfusion period. All hearts initially underwent a 20 min, aerobic 
baseline period, loaded mode (afterload pressure 80 mmHg) with KHB (see composition in 
supplemental material) supplemented with 1.2 mM palmitate and 3% albumin. Control, MH, 
MPC and HY groups were then subjected to 27 min, normothermic global ischemia followed 
by 60 min reperfusion, while hearts in the sham group were maintained in baseline perfusion 
conditions for the equivalent time (27 min) to generate non-ischemic control hearts. In all 
groups, hearts were reperfused for 60 min using KHB without palmitate and albumin 
supplementation. Reperfusion was initiated in unloaded mode for the first 10 min and then 
switched to loaded mode for the remaining 50 min (afterload 60 mmHg). Cardioprotective 
strategies were applied at reperfusion onset as follows: MH, perfusate at 30°C for the first 10 
min of reperfusion; MPC, 2 cycles of 30 sec reperfusion and 30 sec ischemia; and HY, 
perfusate bubbled with 95% N2/ 5% CO2 for the first 2 min of reperfusion.  
AL, afterload (aortic) pressure; HY, hypoxia; MH, mild hypothermia; MPC, mechanical post-
conditioning; R-I, reperfusion-ischemia. 
Figure 2. Percent post-ischemic functional and metabolic recovery. Values are 
presented as 60 min reperfusion values expressed as a percentage of mean baseline 
values. (A) LV work, left-ventricular work (HR*DP); (B) DP, developed pressure; (C) HR, 
heart rate; (D) dP/dtmin, minimum first derivative of LV pressure; (E) dP/dtmax, maximum first 
derivative of LV pressure; (F) CO, cardiac output; (G) Triple product (LV work*dP/dtmax); (H) 
O2C, oxygen consumption. 
#p <0.05, ##p < 0.01, ###p <0.001 vs. sham; *p <0.05, **p <0.01, ***p <0.001 vs. control. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
HY, hypoxia; MH, mild hypothermia; MPC, mechanical post-conditioning. 
Figure 3. Oxygen metabolism before and after global, warm ischemia. (A) O2C, oxygen 
consumption at 20 min baseline and different timepoints during reperfusion (20, 40 and 60 
min); (B) O2:T, oxygen consumption-triple product ratio at 20 min baseline and different 
timepoints during reperfusion (20, 40 and 60 min reperfusion). 
#p <0.05 vs. sham; *p <0.05 vs. control; **p <0.01 vs. control 
HY, hypoxia; MH, mild hypothermia; MPC, mechanical post-conditioning. 
Figure 4. Metabolic and cell death markers during reperfusion. (A) TnT release at 10, 20 
and 60 min reperfusion; (B) LDH release at 10 and 60 min reperfusion; (C) Cyt c release at 
10 and 40 min reperfusion; (D) Lactate accumulation at 10 and 60 min reperfusion. 
#p < 0.05 vs. sham; *p <0.05 vs. control. 
Cyt c, cytochrome c; HY, hypoxia; LDH, lactate dehydrogenase; MH, mild hypothermia; 
MPC, mechanical post-conditioning; N.D, non-detectable; TnT, troponin-T. 
Figure 5. Cardiac content of high energy metabolites after 60 min reperfusion. (A) 
ATP, adenosine triphosphate; (B) PCr, phosphocreatine; (C) ADP, adenosine diphosphate; 
(D) ATP/ADP ratio; all measured in ventricular homogenates. 
#p <0.05, ##p <0.01, ###p <0.001 vs. sham; *p <0.05, ***p <0.001 vs. control. 
HY, hypoxia; MH, mild hypothermia; MPC, mechanical post-conditioning. 
Figure 6. Activity of cardiac enzymes related to energy production after 60 min 
reperfusion. (A) CI activity, mitochondrial complex I, (B) CII activity, mitochondrial complex 
II, (C) AK activity, adenylate kinase, and (D) CK activity, creatine kinase; all measured in 
ventricular homogenates.  
#p <0.05 vs. sham; * p <0.05 vs. control; &p <0.05 vs. MPC; $p <0.05, $$p <0.01 vs. HY. 
HY, hypoxia; IU, international unit; MH, mild hypothermia; MPC, mechanical post-
conditioning. 
Figure 7. Markers of mitochondrial mass after 60 min reperfusion. (A) CS activity, 
citrate synthase, (B) COX activity, cytochrome c oxidase, and (C) mtDNA:nDNA, mtDNA-
nDNA ratio, measure of relative content of mtDNA; all measured in ventricular homogenates. 
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#p <0.05, ##p <0.01, ###p <0.001, vs. sham. 
HY, hypoxia; IU, international unit; MH, mild hypothermia; MPC, mechanical post-
conditioning. 
Figure 8. mRNA expression of genes involved in the mitochondrial biogenesis 
pathway after 60 min reperfusion. (A) Tfam, transcription Factor A, mitochondrial, (B) Nrf1; 
nuclear respiratory factor 1, (C) Nrf2; nuclear respiratory factor 2, (D) Pgc-1α, peroxisome 
proliferator-activated receptor-gamma coactivator α and (E) Pgc-1β, peroxisome proliferator-
activated receptor-gamma coactivator β; all measured in ventricular homogenates. 
* p <0.05 vs. control. 
HY, hypoxia; MH, mild hypothermia; MPC, mechanical post-conditioning. 
Figure 9. Markers of oxidative stress after 60 min reperfusion. (A) TBARS (thiobarbituric 
acid reactive substances) content and (B) Oxyblot, protein carbonylation levels after 
normalization; lower panel, representative oxyblot and Ponceau S images. 
#p < 0.05, ##p < 0.01, vs. sham; all measured in ventricular homogenates. 
AU, arbitrary units; HY, hypoxia; MDA, malondialdehyde; MH, mild hypothermia; MPC, 
mechanical post-conditioning. 
Figure 10. Correlation analysis between recovery, mitochondrial, and metabolic 
parameters, all measured at 60 min reperfusion. Spearman correlations were performed 
for (A) pooled control and mild hypothermia groups; (B) pooled control and mechanical post-
conditioning groups; (C) pooled control and hypoxia groups. Rho values are indicated by the 
colour scale. *p <0.05, **p <0.01, £p <0.001. 
Mitochondrial related-parameters (Y-axis) measured at 60 min reperfusion: AK, adenylate 
kinase activity; ATP, adenosine triphosphate; CI, mitochondrial complex I activity; CII, 
mitochondrial complex II activity; CK, creatine kinase activity; COX, cytochrome c oxidase 
activity; CS, citrate synthase activity; mtDNA:nDNA, mitochondrial-nuclear DNA ratio; O2C, 
oxygen consumption;  PCr, phosphocreatine. 
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Recovery parameters (X-axis): 60 min reperfusion values expressed as percentage recovery 
of baseline (%): HR, heart rate; DP, developed pressure; dP/dtmin, minimum first derivative of 
LV (left ventricle) pressure; dP/dtmax, maximum first derivative of LV pressure; LV work 
(HR*DP); CO, cardiac output; O2C, oxygen consumption; O2:T, oxygen consumption-triple 
product ratio.  
Figure 11. Correlation analysis of mitochondrial, metabolic, and cell death measures 
at 10 min reperfusion with recovery parameters measured at 60 min reperfusion. 
Spearman correlations were performed for A) pooled control and mild hypothermia groups; 
(B) pooled control and mechanical post-conditioning groups; (C) pooled control and hypoxia 
groups. Rho values are indicated by the colour scale. *p < 0.05, **p < 0.01, £p < 0.001. 
Early reperfusion parameters (Y-axis) measured at 10 min reperfusion in perfusate samples: 
cyt c, cytochrome release; LDH, lactate dehydrogenase release; O2C, oxygen consumption; 
O2:T, oxygen consumption-triple product ratio; TnT, troponin-T release.  
Recovery parameters (X-axis): 60 min reperfusion values expressed as percentage recovery 
of baseline (%): AK, adenylate kinase activity; ATP, adenosine triphosphate; CI, 
mitochondrial complex I activity; CII, mitochondrial complex II activity; CK, creatine kinase 
activity; CO, cardiac output; COX, cytochrome c oxidase activity; CS, citrate synthase 
activity; DP, developed pressure; dP/dtmin, minimum first derivative of LV (left ventricle) 
pressure; dP/dtmax, maximum first derivative of LV pressure; HR, heart rate;  LV work 
(HR*DP); mtDNA:nDNA, mitochondrial-nuclear DNA ratio; O2C, oxygen consumption; O2:T, 
oxygen consumption-triple product ratio, PCr, phosphocreatine.  
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